Comparison of two different TSH-receptor antibody assays: A clinical practice study., PMID:38107298
Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report., PMID:38111423
Transition from Hashimoto thyroiditis to Graves's Disease: an unpredictable change?, PMID:38117453
The evaluation of retrobulbar fat tissue in Graves' orbitopathy with shear-wave ultrasound elastography., PMID:38321200
The full-length TSH receptor is stabilized by TSH ligand., PMID:38373379
Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor., PMID:38447802
A Novel TSHR Gene Mutation in a Family with Non-autoimmune Hyperthyroidism., PMID:38566871
A TSHR-Targeting Aptamer in Monocytes Correlating with Clinical Activity in TAO., PMID:38650837
A Novel Association Between Human Papillomavirus and Thyroid Eye Disease., PMID:38746201
Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report., PMID:38813368
Immune checkpoints: new insights into the pathogenesis of thyroid eye disease., PMID:38817600
Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment., PMID:38820506
Graves disease: latest understanding of pathogenesis and treatment options., PMID:39039206
Identification and functionalization of thyrotropin receptor antibodies with different antigenic epitopes., PMID:39046281
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease., PMID:39082947
TSH Receptor Oligomers Associated With the TSH Receptor Antibody Reactome., PMID:39116382
Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer., PMID:39174789
Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy., PMID:39280007
Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant., PMID:39301178
STAT3 single-nucleotide variants in autoimmune thyroid disease in the Pakhtun population of Khyber Pakhtunkhwa, Pakistan., PMID:39385969
Hypothyroidism Induced by a TSH Receptor Peptide-Implications for Thyroid Autoimmunity., PMID:39435685
Proangiogenic effect of thyrotropin receptor stimulating antibody in human umbilical vein endothelial cells., PMID:39455509
The TSH Receptor Antibody Reactome Contributes to Retro-Orbital Inflammation., PMID:39502473
A novel bioassay for thyroid-blocking immunoglobulins., PMID:39534254
Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves' disease., PMID:39669491
Mutation spectra and genotype‑phenotype analysis of congenital hypothyroidism in a neonatal population., PMID:39720292
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells., PMID:39723207
Effects of linsitinib on M22 and IGF:1-treated 3D spheroids of human orbital fibroblasts., PMID:39747159
Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders., PMID:39754930
Establishment of Time-Resolved Fluorescence Immunoassay for Thyrotropin Receptor Antibodies and Clinical Application., PMID:39776097
Mechanisms in Thyroid Eye Disease: The TSH Receptor Interacts Directly With the IGF-1 Receptor., PMID:39821041
The role of autophagy in Graves disease: knowns and unknowns., PMID:39834383
Thyroid-Targeted Nano-Bombs Empower HIFU for Graves' Disease., PMID:39840533
Development of animal models to study aggressive thyroid cancers., PMID:39874138
Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy., PMID:39909461
Thyroid dermopathy and thyroid eye disease associated with hypofunctional autoimmune thyroid disease with high TSI/anti-TSHR antibodies improved with teprotumumab., PMID:39950657
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs., PMID:39992626
Inflammatory and tolerogenic dendritic cells and T lymphocytes in Graves' thyroidal and orbital disease., PMID:40024060
Antibodies against the receptor for insulin-like growth factor 1 (IGF-1RAb), insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP-3) in the serum of patients with Graves' and Basedow's disease with and without orbitopathy., PMID:40071798
Chimeric autoantibody receptor T cells specifically eliminate Graves' Disease autoreactive B cells., PMID:40264771
Bacteroides fragilis and propionate synergize with low-dose methimazole to treat Graves' disease., PMID:40265938
Human Papillomavirus and Thyroid Eye Disease., PMID:40272832
Thyroid-related orbitopathy: clinical overview, novel medical treatments and the role of orbital surgery., PMID:40317422
Follicular helper T cells in Graves' disease: pathogenic mechanisms and therapeutic implications., PMID:40322944
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management., PMID:40324443
Molecular pathway and mechanism responsible for the progress of thyroid-associated orbitopathy., PMID:40381066
Marked Increase in Thyrotropin Receptor Antibodies With the Development of Pretibial Myxedema After Total Thyroidectomy., PMID:40384886
Preclinical ImmunoPET Imaging of Thyroid-Stimulating Hormone Receptor Expression in Thyroid Cancer using [64Cu]Cu-NOTA-TSHR-Ab., PMID:40403201
TSH Receptor Antibody Test Utilization Patterns from a National Reference Laboratory: TRAb, TSI, or Both?, PMID:40482060
Monoclonal Antibodies to Thyrotropin Receptor With Thyroid-Stimulating Activity Activate the NF-κB Pathway to Induce Chemokine Expression., PMID:40500868
For research use only. Not for human or drug use.
